Pharmaceutical News

RSS

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

In the current issue of Psychotherapy and Psychosomatic, professor Guy Chouinard, one of the most important psychopharmacologists, provides a synthesis of the data that are concerned with neglected side effects of commonly used psychotropic drugs.

8 Sep 2017

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Eli Lilly and Company announced yesterday that they have decided to lay off around 8.5 percent of their employees. The company was on its way to develop two potential major drugs over the past year but set backs have led to major financial losses, leading to this decision.

7 Sep 2017

Generic drug used to increase blood flow may improve effectiveness of cancer immunotherapy

Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.

7 Sep 2017

CFDA's NIFDC and IIVS re-affirm, expand partnership to bring non-animal test methods to China

Bo Li, Director General Director of the CFDA's National Institute for Food and Drug Control and Erin Hill, President of US based non-profit, Institute for In Vitro Sciences, Inc., signed a Memorandum of Understanding to bring non-animal test methods to China for the regulation of cosmetics and ingredients.

7 Sep 2017

Research shows new method for rapidly producing antimalarial drug at industrial scale

Compared to smallpox or typhoid, malaria is proving one of the most challenging human diseases to eradicate - and so remains a real and constant danger to nearly half the world's population.

7 Sep 2017

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.

7 Sep 2017

Researchers define how cancer drug works in cells, mice and man

Science is very good at determining how drugs work in experimental models. New research out of Dartmouth's Norris Cotton Cancer Center led by Alan Eastman, PhD, helps to bridge the gap when it comes to ensuring that drugs work by the same mechanism in human patients.

7 Sep 2017

Researchers study two new drugs to find alternative treatment for men with erectile dysfunction

Close to 70 percent of men with erectile dysfunction (ED) respond to the ED drug sildenafil. However, only about 50 percent of men with diabetes- a population commonly affected by ED- achieve positive results with sildenafil.

6 Sep 2017

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.

6 Sep 2017

Heparin promotes food intake and body weight gain in animal models

Heparin is a medication widely used to prevent blood clotting; it is named after and mimics the naturally occurring anticoagulant in the body.

6 Sep 2017

Existing antidepressant drug could slow progression of Parkinson’s

Michigan State University scientists now have early proof that an antidepressant drug that's been around for more than 50 years could slow the progression of Parkinson's.

6 Sep 2017

Antidepressants used for chronic pain relief come with significant side effects

Chronic pain negatively impacts a person's quality of life. Often, over the counter pain medication, such as ibuprofen or aspirin, are ineffective in alleviating chronic pain. In these instances, a surprising choice is often a drug used to treat an entirely different condition - depression.

5 Sep 2017

Mild pain killer blocks action of key protein required for hearing

A Rice University study has found that the aspirin-like drug diflunisal blocks the action of prestin, a key protein that is required for hearing.

5 Sep 2017

Scientists show how receptors for drugs act inside cells

G protein-coupled receptors are the key target of a large number of drugs. Würzburg scientists have now been able to show more precisely how these receptors act in the cell interior.

5 Sep 2017

Study finds antibiotic overprescribing for white children treated in pediatric emergency departments

White children with viral diagnoses treated in pediatric emergency departments were up to twice as likely to receive antibiotics compared to minority children, according to a study published in Pediatrics.

5 Sep 2017

Study: Low long-term use of psychiatric drugs does not appear to affect cognition in schizophrenia

A long-term study has found that low cumulative exposure to benzodiazepine and antidepressant medications does not seem to affect cognition in schizophrenia.

5 Sep 2017

Better understanding of serotonin's function in the brain could lead to radical shift in psychiatric care

A better understanding of how a key chemical messenger acts in the brain could lead to a radical shift in psychiatric care, according to a new research paper.

4 Sep 2017

Mayo Clinic experts move closer to realizing clinical potential of senolytic drugs on aging

Researchers are moving closer to realizing the clinical potential of drugs that have previously been shown to support healthy aging in animals.

4 Sep 2017

Researchers develop innovative methodology for evaluating benefits of new medicines

An innovative new methodology for evaluating the benefits of new medicines has been developed by a team of researchers led by health economics and policy experts from the Department of Health Policy at the London School of Economics and Political Science.

4 Sep 2017

Pharmaceutical News

Meningitis B vaccine’s high price tag poses a health care conundrum

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Generic drug used to increase blood flow may improve effectiveness of cancer immunotherapy

CFDA's NIFDC and IIVS re-affirm, expand partnership to bring non-animal test methods to China

Research shows new method for rapidly producing antimalarial drug at industrial scale

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Researchers define how cancer drug works in cells, mice and man

Researchers study two new drugs to find alternative treatment for men with erectile dysfunction

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Heparin promotes food intake and body weight gain in animal models

Existing antidepressant drug could slow progression of Parkinson’s

Antidepressants used for chronic pain relief come with significant side effects

Mild pain killer blocks action of key protein required for hearing

Scientists show how receptors for drugs act inside cells

Study finds antibiotic overprescribing for white children treated in pediatric emergency departments

Study: Low long-term use of psychiatric drugs does not appear to affect cognition in schizophrenia

Better understanding of serotonin's function in the brain could lead to radical shift in psychiatric care

Mayo Clinic experts move closer to realizing clinical potential of senolytic drugs on aging

Researchers develop innovative methodology for evaluating benefits of new medicines

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News